Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015068 |
1-(3-chlorophenyl)piperazine |
1-(3-chlorophenyl)piperazine binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
C015068 |
1-(3-chlorophenyl)piperazine |
HTR2A gene SNP results in increased susceptibility to 1-(3-chlorophenyl)piperazine | increases response to substance | 16314884
|
C015068 |
1-(3-chlorophenyl)piperazine |
HTR2A protein affects the susceptibility to 1-(3-chlorophenyl)piperazine | affects response to substance | 16314884
|
C118559 |
1-bromopropane |
1-bromopropane results in decreased expression of HTR2A mRNA | decreases expression | 19576243
|
C015952 |
4-iodo-2,5-dimethoxyphenylisopropylamine |
4-iodo-2,5-dimethoxyphenylisopropylamine binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
C015952 |
4-iodo-2,5-dimethoxyphenylisopropylamine |
HTR2A gene SNP results in decreased susceptibility to 4-iodo-2,5-dimethoxyphenylisopropylamine | decreases response to substance | 16314884
|
C015952 |
4-iodo-2,5-dimethoxyphenylisopropylamine |
HTR2A protein affects the susceptibility to 4-iodo-2,5-dimethoxyphenylisopropylamine | affects response to substance | 16314884
|
C015952 |
4-iodo-2,5-dimethoxyphenylisopropylamine |
4-iodo-2,5-dimethoxyphenylisopropylamine binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 12482207
|
C095512 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein] | affects binding|decreases activity|decreases reaction|increases expression|increases phosphorylation | 18976543
|
C095512 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[MDL 100907 binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein] | affects binding|decreases activity|decreases reaction|increases expression|increases phosphorylation | 18976543
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HTR2A mRNA | affects expression | 16483693
|
C094645 |
aripiprazole |
aripiprazole binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
C094645 |
aripiprazole |
aripiprazole inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
C094645 |
aripiprazole |
HTR2A gene SNP results in decreased susceptibility to aripiprazole | decreases response to substance | 16314884
|
C094645 |
aripiprazole |
HTR2A protein affects the susceptibility to aripiprazole | affects response to substance | 16314884
|
C094645 |
aripiprazole |
aripiprazole binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 17069544
|
D002118 |
Calcium |
HTR2A protein promotes the reaction [[Freund's Adjuvant results in increased activity of TRPV1 protein] which results in increased transport of Calcium] | increases activity|increases reaction|increases transport | 16901936
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of HTR2A mRNA | increases expression | 16644059 12832660
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of HTR2A | increases expression | 17035140
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of HTR2A mRNA | increases expression | 17452286
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in increased expression of HTR2A mRNA alternative form | increases expression | 17452286
|
D003024 |
Clozapine |
Clozapine analog binds to HTR2A protein | affects binding | 11997696
|
D003024 |
Clozapine |
Clozapine binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 20521326 16314884
|
D003024 |
Clozapine |
Clozapine binds to HTR2A protein | affects binding | 16983399 11997696
|
D003024 |
Clozapine |
Clozapine inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D003024 |
Clozapine |
HTR2A gene SNP results in increased susceptibility to Clozapine | increases response to substance | 16314884
|
D003024 |
Clozapine |
HTR2A protein affects the susceptibility to Clozapine | affects response to substance | 16314884
|
D003024 |
Clozapine |
Clozapine results in increased expression of HTR2A mRNA | increases expression | 15542763
|
D003024 |
Clozapine |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein] | affects binding|decreases activity|decreases reaction|increases expression|increases phosphorylation | 18976543
|
D003024 |
Clozapine |
Clozapine binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 18976543
|
D003024 |
Clozapine |
[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein | affects binding|decreases activity|increases phosphorylation | 18976543
|
D003024 |
Clozapine |
[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein | affects binding|decreases activity|increases expression|increases phosphorylation | 18976543
|
D003024 |
Clozapine |
Clozapine promotes the reaction [Phencyclidine results in decreased activity of HTR2A protein] | decreases activity|increases reaction | 15380371
|
D003024 |
Clozapine |
Clozapine results in decreased activity of HTR2A protein | decreases activity | 15380371
|
D003024 |
Clozapine |
Clozapine results in decreased expression of HTR2A mRNA | decreases expression | 17868938 14751426
|
D003024 |
Clozapine |
Clozapine results in decreased expression of HTR2A protein | decreases expression | 14751426
|
C079149 |
clozapine N-oxide |
clozapine N-oxide results in decreased expression of HTR2A protein | decreases expression | 14751426
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of HTR2A mRNA | increases expression | 15755911
|
D003976 |
Diazinon |
Diazinon promotes the reaction [Ketanserin binds to HTR2A protein] | affects binding|increases reaction | 17035140
|
D003976 |
Diazinon |
Diazinon results in increased expression of HTR2A mRNA | increases expression | 17452286
|
D003976 |
Diazinon |
Diazinon results in increased expression of HTR2A protein | increases expression | 17035140
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of HTR2A mRNA | increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HTR2A mRNA] | decreases reaction|increases expression | 17942915
|
D004130 |
N,N-Dimethyltryptamine |
HTR2A gene SNP results in decreased susceptibility to N,N-Dimethyltryptamine | decreases response to substance | 16314884
|
D004130 |
N,N-Dimethyltryptamine |
HTR2A protein affects the susceptibility to N,N-Dimethyltryptamine | affects response to substance | 16314884
|
D004130 |
N,N-Dimethyltryptamine |
N,N-Dimethyltryptamine binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate results in increased expression of HTR2A mRNA | increases expression | 17398000
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate results in increased expression of HTR2A protein | increases expression | 17398000
|
C074283 |
estradiol 3-benzoate |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A mRNA] | decreases reaction|increases expression | 17398000
|
C074283 |
estradiol 3-benzoate |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A protein] | decreases reaction|increases expression | 17398000
|
D004958 |
Estradiol |
[Estradiol co-treated with Sertraline] affects the expression of HTR2A mRNA | affects cotreatment|affects expression | 18650020
|
D004958 |
Estradiol |
Estradiol promotes the reaction [Sertraline results in increased expression of HTR2A mRNA] | increases expression|increases reaction | 18650020
|
D016666 |
Fluvoxamine |
HTR2A gene SNP affects the susceptibility to Fluvoxamine | affects response to substance | 12607287
|
D005620 |
Freund's Adjuvant |
Freund's Adjuvant results in increased expression of HTR2A mRNA | increases expression | 16901936
|
D005620 |
Freund's Adjuvant |
HTR2A protein promotes the reaction [[Freund's Adjuvant results in increased activity of TRPV1 protein] which results in increased transport of Calcium] | increases activity|increases reaction|increases transport | 16901936
|
D006220 |
Haloperidol |
[Phencyclidine co-treated with Haloperidol] affects the activity of HTR2A protein | affects activity|affects cotreatment | 15380371
|
D012701 |
Serotonin |
HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein] | affects reaction|increases activity | 18621911
|
D012701 |
Serotonin |
Ketanserin inhibits the reaction [HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein]] | affects reaction|decreases reaction|increases activity | 18621911
|
D012701 |
Serotonin |
HTR2A gene SNP results in decreased susceptibility to Serotonin | decreases response to substance | 16314884
|
D012701 |
Serotonin |
HTR2A protein affects the susceptibility to Serotonin | affects response to substance | 16314884
|
D012701 |
Serotonin |
Serotonin binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
D012701 |
Serotonin |
HTR2A protein affects the reaction [Serotonin affects the phosphorylation of PPP1R1B protein] | affects phosphorylation|affects reaction | 11880652
|
D007650 |
Ketanserin |
Ketanserin inhibits the reaction [HTR2A protein affects the reaction [Serotonin results in increased activity of PLD1 protein]] | affects reaction|decreases reaction|increases activity | 18621911
|
D007650 |
Ketanserin |
aripiprazole inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D007650 |
Ketanserin |
Clozapine inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D007650 |
Ketanserin |
Ketanserin binds to HTR2A protein | affects binding | 2891550 16314884
|
D007650 |
Ketanserin |
quetiapine inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D007650 |
Ketanserin |
Spiperone inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 2891550
|
D007650 |
Ketanserin |
ziprasidone inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D007650 |
Ketanserin |
Ketanserin binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 10978843
|
D007650 |
Ketanserin |
Diazinon promotes the reaction [Ketanserin binds to HTR2A protein] | affects binding|increases reaction | 17035140
|
D007650 |
Ketanserin |
Ketanserin inhibits the reaction [Tramadol results in increased activity of HTR2A protein] | decreases reaction|increases activity | 18417104
|
D007650 |
Ketanserin |
Ketanserin binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 15542624
|
C079049 |
MDL 100907 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[MDL 100907 binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein] | affects binding|decreases activity|decreases reaction|increases expression|increases phosphorylation | 18976543
|
C079049 |
MDL 100907 |
MDL 100907 binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 18976543
|
C079049 |
MDL 100907 |
[MDL 100907 binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein | affects binding|decreases activity|increases phosphorylation | 18976543
|
C079049 |
MDL 100907 |
[[MDL 100907 binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein | affects binding|decreases activity|increases expression|increases phosphorylation | 18976543
|
D008803 |
Mianserin |
Mianserin binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 10978843
|
D009532 |
Nickel |
Nickel results in decreased expression of HTR2A mRNA | decreases expression | 18835401
|
C058272 |
norclozapine |
norclozapine results in decreased expression of HTR2A mRNA | decreases expression | 14751426
|
C058272 |
norclozapine |
norclozapine results in decreased expression of HTR2A protein | decreases expression | 14751426
|
C076029 |
olanzapine |
olanzapine binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 20521326
|
C076029 |
olanzapine |
olanzapine binds to HTR2A protein | affects binding | 16983399
|
C076029 |
olanzapine |
olanzapine binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 18976543
|
C076029 |
olanzapine |
[olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein | affects binding|decreases activity|increases phosphorylation | 18976543
|
C076029 |
olanzapine |
[[olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein | affects binding|decreases activity|increases expression|increases phosphorylation | 18976543
|
D010269 |
Paraquat |
Paraquat results in decreased expression of HTR2A mRNA | decreases expression | 17077588
|
D010278 |
Parathion |
Parathion results in decreased expression of HTR2A protein | decreases expression | 17035140
|
D017374 |
Paroxetine |
HTR2A gene polymorphism affects the susceptibility to Paroxetine | affects response to substance | 17503984
|
D010622 |
Phencyclidine |
Clozapine promotes the reaction [Phencyclidine results in decreased activity of HTR2A protein] | decreases activity|increases reaction | 15380371
|
D010622 |
Phencyclidine |
[Phencyclidine co-treated with Haloperidol] affects the activity of HTR2A protein | affects activity|affects cotreatment | 15380371
|
D010622 |
Phencyclidine |
Phencyclidine results in decreased activity of HTR2A protein | decreases activity | 15380371
|
C069541 |
quetiapine |
quetiapine inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
D020849 |
Raloxifene |
Raloxifene affects the expression of HTR2A mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A mRNA] | decreases reaction|increases expression | 17398000
|
D020849 |
Raloxifene |
Raloxifene inhibits the reaction [estradiol 3-benzoate results in increased expression of HTR2A protein] | decreases reaction|increases expression | 17398000
|
D018967 |
Risperidone |
HTR2A gene SNP results in increased susceptibility to Risperidone | increases response to substance | 16314884
|
D018967 |
Risperidone |
HTR2A protein affects the susceptibility to Risperidone | affects response to substance | 16314884
|
D018967 |
Risperidone |
Risperidone binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 16314884
|
D018967 |
Risperidone |
Risperidone binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 16948927
|
D016713 |
Ritanserin |
Ritanserin binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 19228979
|
D020280 |
Sertraline |
[Estradiol co-treated with Sertraline] affects the expression of HTR2A mRNA | affects cotreatment|affects expression | 18650020
|
D020280 |
Sertraline |
Estradiol promotes the reaction [Sertraline results in increased expression of HTR2A mRNA] | increases expression|increases reaction | 18650020
|
D020280 |
Sertraline |
Sertraline results in increased expression of HTR2A mRNA | increases expression | 18650020
|
D013134 |
Spiperone |
Spiperone inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 2891550
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of HTR2A mRNA | affects expression | 14699072
|
D014147 |
Tramadol |
Ketanserin inhibits the reaction [Tramadol results in increased activity of HTR2A protein] | decreases reaction|increases activity | 18417104
|
D014147 |
Tramadol |
Tramadol results in increased activity of HTR2A protein | increases activity | 18417104
|
D014147 |
Tramadol |
Tramadol results in increased expression of HTR2A mRNA | increases expression | 18417104
|
D014196 |
Trazodone |
Trazodone binds to and results in decreased activity of HTR2A protein | affects binding|decreases activity | 19623435 19711746
|
C030820 |
tryptamine |
HTR2A gene SNP results in decreased susceptibility to tryptamine | decreases response to substance | 16314884
|
C030820 |
tryptamine |
HTR2A protein affects the susceptibility to tryptamine | affects response to substance | 16314884
|
C030820 |
tryptamine |
tryptamine binds to and results in increased activity of HTR2A protein | affects binding|increases activity | 16314884
|
C092292 |
ziprasidone |
ziprasidone inhibits the reaction [Ketanserin binds to HTR2A protein] | affects binding|decreases reaction | 16314884
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.10 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.12 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.18 | 16166738 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
1.98 | 11473722 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.59 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.46 | 17162532 19061943 18056438 17620307 16434500 19052882 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.62 | 12649775 16160616 14617031 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
16.91 | 11874814 16611668 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
16.91 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
16.91 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Parathion |
16.91 | 17119214 11874814 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.17 | 17308373 17451421 |
MESH:D000437 |
Alcoholism |
marker/mechanism |
|
| |
MESH:D000544 |
Alzheimer Disease |
|
1-(3-chlorophenyl)piperazine |
6.53 | 1912105 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
6.53 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
Trazodone |
6.53 | 16856516 17897735 |
MESH:D000856 |
Anorexia Nervosa |
marker/mechanism |
|
| |
MESH:D001008 |
Anxiety Disorders |
|
Sertraline |
4.75 | 18822694 |
MESH:D020817 |
Asperger Syndrome |
|
aripiprazole |
10.55 | 19519261 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
10.55 | 16401163 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
aripiprazole |
8.38 | 17069544 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
8.38 | 18349709 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17280648 |
MESH:D001321 |
Autistic Disorder |
|
aripiprazole |
6.80 | 17069544 |
MESH:D001321 |
Autistic Disorder |
|
Fluvoxamine |
6.80 | 12607287 18775368 19232924 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
6.80 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
6.80 | 18685284 17069543 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
6.80 | 19368416 17929164 18026891 18775368 16379507 17019624 17069546 15543515 19013209 19232924 16239862 18349709 16948927 15930063 15492353 15994720 16730335 18080171 18278980 16601648 19154706 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
6.80 | 19221690 18405062 18361446 8570775 17157402 15132762 18062943 |
MESH:D001321 |
Autistic Disorder |
|
Sertraline |
6.80 | 18775368 |
MESH:D001321 |
Autistic Disorder |
|
ziprasidone |
6.80 | 18315450 |
MESH:D001714 |
Bipolar Disorder |
marker/mechanism |
|
| 14708030 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
4.28 | 19154706 18278980 |
MESH:D001862 |
Bone Resorption |
|
Freund's Adjuvant |
4.73 | 16769263 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.03 | 8112388 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.04 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.72 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.72 | 17289903 16675129 12948864 17018787 18497071 17261762 14630087 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.72 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Parathion |
2.72 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.72 | 15758505 17595753 16912660 17952589 15572757 17440819 17893378 17049068 16837676 17261762 17242785 15775269 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.72 | 19200415 19011961 18984771 19155303 21152245 18815881 19410462 15668708 16273361 15565566 18821012 17893378 19289846 18629630 17049068 18855134 19066611 19189210 19244106 20544844 19059307 19221464 21138602 19142967 17242785 19084267 16818667 19189212 20390343 16202921 19103187 19115204 20859285 18351453 16873071 11161223 17440819 20135344 19288272 20065188 20005174 19487384 18997820 18425577 17261762 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.02 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.35 | 16097048 15721981 16192424 15673190 3786805 15700767 18705752 16227642 10355542 16124888 16050911 16011737 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.07 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
5.87 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
5.87 | 17162532 16935385 20512989 19171122 19822196 19052882 19418558 19701751 19519916 18393292 17428255 3084413 10737359 18788625 18665156 17055752 16779866 17978847 18971187 16878318 16698587 16569478 18785209 19539802 21159647 18210153 16681979 20727157 18691550 16288022 18056438 17761372 20084675 20514400 20524982 20214788 18494052 16328049 20432363 10672840 16807293 18506893 18978308 19208518 11831363 19919837 19383236 16502159 19107877 16540662 19394651 17173139 20935162 17138121 16830150 20007298 20101231 3581430 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
5.87 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
5.87 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.23 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.23 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.14 | 15775269 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.47 | 1977408 15215559 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.80 | 18071103 16772815 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
5.67 | 17174075 7505956 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.67 | 18566989 |
MESH:D002637 |
Chest Pain |
|
Trazodone |
5.57 | 15238202 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
aripiprazole |
6.65 | 19519261 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
6.65 | 21254450 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.31 | 19052882 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.24 | 17157402 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
10.24 | 17123785 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
10.24 | 15800139 |
MESH:D003128 |
Coma |
|
Trazodone |
5.68 | 10836866 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Mianserin |
4.28 | 10978843 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ritanserin |
4.28 | 10978843 14991402 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
10.10 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
10.10 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
14.63 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
14.63 | 11575062 |
MESH:D003704 |
Dementia |
|
Trazodone |
14.63 | 12587811 11575062 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.93 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
Fluvoxamine |
20.82 | 19571598 |
MESH:D003866 |
Depressive Disorder |
|
Mianserin |
20.82 | 18083778 |
MESH:D003866 |
Depressive Disorder |
|
Paroxetine |
20.82 | 15014590 17072103 |
MESH:D003866 |
Depressive Disorder |
|
Sertraline |
20.82 | 20305041 15014590 18822694 |
MESH:D003866 |
Depressive Disorder |
|
Trazodone |
20.82 | 4066620 3378227 19623435 3690436 20305041 15014590 18083778 |
MESH:D003865 |
Depressive Disorder, Major |
marker/mechanism |
|
| |
MESH:D003865 |
Depressive Disorder, Major |
|
Fluvoxamine |
20.64 | 17474826 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
20.64 | 17474826 |
MESH:D003865 |
Depressive Disorder, Major |
|
Sertraline |
20.64 | 16968574 |
MESH:D003865 |
Depressive Disorder, Major |
|
Trazodone |
20.64 | 16968574 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.54 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.23 | 2952479 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.39 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.28 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.28 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
12.87 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
12.87 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
12.87 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
4.36 | 11488427 8112388 10446763 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
12.94 | 15331141 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
12.94 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
6.22 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
4.74 | 18349709 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.44 | 15027814 16177239 6884620 17522070 10092053 7440962 3786805 9327722 6623471 21278145 7120509 4309450 3732212 15968718 11566570 19085960 15998439 16227642 7179309 2869522 19336974 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.44 | 19107877 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
Trazodone |
5.48 | 3690436 |
MESH:D020820 |
Dyskinesias |
marker/mechanism |
|
| 11526996 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.86 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.35 | 16487989 |
MESH:D004421 |
Dystonia |
|
Trazodone |
5.23 | 3700695 |
MESH:D004487 |
Edema |
|
Raloxifene |
9.74 | 15860553 |
MESH:D004487 |
Edema |
|
Serotonin |
9.74 | 18841975 |
MESH:D004487 |
Edema |
|
Trazodone |
9.74 | 12798668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
7.85 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.85 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.41 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.41 | 16202921 20544844 19155303 17893378 |
MESH:D007172 |
Erectile Dysfunction |
|
Trazodone |
5.06 | 7604472 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.66 | 16302075 |
MESH:D020329 |
Essential Tremor |
|
Trazodone |
5.67 | 3296121 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
15.57 | 12631006 61145 12795759 19224547 15959796 16239168 17595544 16045604 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.57 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
15.57 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.57 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.96 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.08 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.03 | 18705752 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.71 | 11124998 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ritanserin |
5.07 | 14991402 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.23 | 11110106 |
MESH:D018883 |
Heat Stroke |
|
Ketanserin |
6.72 | 16205318 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.22 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
8.22 | 16487989 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.58 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.58 | 17263646 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
14.90 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Paroxetine |
14.90 | 14716179 |
MESH:D019584 |
Hot Flashes |
|
Trazodone |
14.90 | 19711746 |
MESH:D006816 |
Huntington Disease |
|
Sertraline |
5.59 | 18403212 |
MESH:D006930 |
Hyperalgesia |
|
Freund's Adjuvant |
7.81 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
Trazodone |
7.81 | 12790215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.09 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
4.78 | 18278980 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.47 | 16046005 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.79 | 17933447 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.69 | 15787275 17577099 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.66 | 15338365 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Trazodone |
5.57 | 15811171 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
9.87 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
9.87 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
Parathion |
9.87 | 16029889 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
13.35 | 18785209 |
MESH:D007249 |
Inflammation |
|
Freund's Adjuvant |
13.35 | 16793879 |
MESH:D007249 |
Inflammation |
|
Nickel |
13.35 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
13.35 | 19457130 |
MESH:D007249 |
Inflammation |
|
Trazodone |
13.35 | 12798668 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.67 | 16627594 16393666 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.33 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.20 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.20 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.59 | 16316344 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.09 | 16973256 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
11.55 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Sertraline |
11.55 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
11.55 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.76 | 16943688 11903743 11408273 16221502 17157831 17174718 17334410 16239168 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.76 | 20032147 18407596 18665156 19638242 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.15 | 14620537 17900296 12632514 14724832 18277467 18481824 18472332 11481614 17698563 16033810 17823541 18705752 17761835 17944888 18395914 16097048 17805973 15057751 15370692 18166357 16248980 20821823 18006644 18395095 18412020 18205269 17714472 13678700 18376398 15876570 14716496 17640975 16136751 12445421 14512876 17976157 15931870 18317297 14748882 12667390 17708605 17525996 12649538 16192424 16638106 12632512 18210741 16011737 17922224 18418968 15730626 18263696 12546737 14716833 12666154 16116963 17557913 18156304 18054572 15996030 15818738 18429990 15338365 17766677 12445418 15959796 12898905 16027843 18472094 12586293 17869086 12958196 15925388 15052691 15673190 15362042 12389079 12741479 17481882 18279442 18251166 18339082 16015684 17721639 10355542 18187930 15893842 15650968 18420326 17565644 17631135 15123356 12609069 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.15 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.15 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.89 | 16964402 16246199 15720792 17285989 15830285 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
5.89 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.89 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.73 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.93 | 14706259 16899240 |
MESH:D017114 |
Liver Failure, Acute |
|
Trazodone |
8.93 | 19857765 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
6.39 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
6.39 | 20405173 19638242 20501860 20452335 19551842 18644402 19256749 12112319 9163691 18977376 19850985 21278145 20434301 18754104 19642983 19690152 19073162 19812893 19090486 19426721 20492335 19499222 19255062 20101389 21167192 19294768 10737359 15175105 15885732 18648771 2862719 12771043 19996281 20137499 18978307 19254457 21071580 19427195 20118626 21047994 20583210 19833225 2422723 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
6.39 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.02 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.02 | 3124819 16267830 19126423 18544905 18093689 18079962 2563599 19009564 17854601 18775883 19519916 19539802 18308698 16842330 9362446 18282651 18253720 18164116 19004024 17942915 21159647 17174075 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
8.08 | 20210726 |
MESH:D008133 |
Long QT Syndrome |
|
Trazodone |
8.08 | 18167038 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.29 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.29 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.32 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
11.99 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.99 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
estradiol 3-benzoate |
11.99 | 15375486 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.99 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.14 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.14 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.82 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.74 | 15990972 |
MESH:D001523 |
Mental Disorders |
|
aripiprazole |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Fluvoxamine |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Mianserin |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Paroxetine |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
quetiapine |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
58.07 | 16596465 16856516 |
MESH:D001523 |
Mental Disorders |
|
Sertraline |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Trazodone |
58.07 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
ziprasidone |
58.07 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
aripiprazole |
6.54 | 16891339 17069544 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
6.54 | 18349709 |
MESH:D008659 |
Metabolic Diseases |
marker/mechanism |
|
| 19142110 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
4.99 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
8.98 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
8.98 | 19142101 |
MESH:D008881 |
Migraine Disorders |
marker/mechanism |
|
| 12482207 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.10 | 15863610 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
5.40 | 17019624 |
MESH:D009069 |
Movement Disorders |
|
Trazodone |
5.35 | 4066620 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.12 | 16497877 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.94 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.10 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.09 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.09 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.36 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.55 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.29 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.38 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.23 | 16427766 11399458 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
2.98 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.66 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
3.86 | 15081274 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
5.88 | 17822346 |
MESH:D009765 |
Obesity |
marker/mechanism |
|
| 17097612 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.97 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
olanzapine |
4.97 | 18515891 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
marker/mechanism |
|
| |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Paroxetine |
5.66 | 17503984 |
MESH:D053578 |
Opsoclonus-Myoclonus Syndrome |
|
Trazodone |
6.01 | 1318289 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
6.59 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.59 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.82 | 17823083 15579764 15758505 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.07 | 19401270 |
MESH:D010146 |
Pain |
|
Tramadol |
7.10 | 18204346 |
MESH:D010146 |
Pain |
|
Trazodone |
7.10 | 12790215 12798668 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.26 | 16540662 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.64 | 12911755 16140633 15451049 15824117 11445065 11124998 11181820 16510128 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
10.06 | 16190885 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Trazodone |
10.06 | 3378227 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.01 | 12504350 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.95 | 17603234 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.18 | 2563599 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.49 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.75 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.75 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.75 | 15067354 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
10.38 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
10.38 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
marker/mechanism |
|
| 14708030 |
MESH:D011618 |
Psychotic Disorders |
|
aripiprazole |
13.08 | 16891339 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
13.08 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
13.08 | 11575062 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Trazodone |
5.68 | 8520792 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.73 | 16324872 17997886 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.10 | 15770314 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.50 | 11700416 |
MESH:D012131 |
Respiratory Insufficiency |
|
Trazodone |
5.35 | 8520792 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
13.87 | 17119214 16611668 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
13.87 | 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Parathion |
13.87 | 11874814 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
9.77 | 16611668 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Parathion |
9.77 | 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.54 | 16458197 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18513383 14708030 |
MESH:D012559 |
Schizophrenia |
|
aripiprazole |
15.24 | 16891339 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
15.24 | 17726453 19369910 20107430 20168265 18855531 20521320 20580759 17667964 20452607 18806925 20521326 16141801 11763009 17123785 11151749 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
15.24 | 20107430 19369910 1830565 18513383 |
MESH:D012559 |
Schizophrenia |
|
norclozapine |
15.24 | 11151749 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
15.24 | 17726453 20107430 20521326 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
15.24 | 19154706 18278980 20107430 |
MESH:D012559 |
Schizophrenia |
|
Trazodone |
15.24 | 7868106 |
MESH:D020230 |
Serotonin Syndrome |
|
Trazodone |
5.68 | 8704074 7854515 9050436 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.64 | 6418539 |
MESH:D012892 |
Sleep Deprivation |
|
Trazodone |
5.81 | 19798453 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
10.14 | 18278980 |
MESH:D012893 |
Sleep Disorders |
|
Trazodone |
10.14 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Trazodone |
4.99 | 17225163 15062207 15341891 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.84 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.60 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D020521 |
Stroke |
|
Raloxifene |
8.12 | 16837676 |
MESH:D020521 |
Stroke |
|
Trazodone |
8.12 | 810300 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Mianserin |
9.84 | 12749364 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Trazodone |
9.84 | 12749364 393279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
27.88 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
27.88 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
27.88 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Trazodone |
27.88 | 2424891 |
MESH:D017180 |
Tachycardia, Ventricular |
|
ziprasidone |
27.88 | 20210726 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.65 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.21 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.21 | 19048282 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
5.51 | 19154706 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
4.60 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.60 | 16712894 8653321 17572228 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.83 | 16487989 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.76 | 16837676 |
MESH:D018879 |
Ventricular Premature Complexes |
|
Trazodone |
6.37 | 2424891 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.10 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
14.47 | 20564506 20107430 16402076 17502770 16141801 20521320 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
14.47 | 17933447 19434072 20107430 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
14.47 | 16379507 20564506 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.63 | 17933447 |